Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-26-023615

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 33.37M sh
Shares Diluted Q1 2026 · Mar 31, 2026 33.37M sh
Shares Diluted Q1 2026 · Mar 31, 2025 33.37M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 $99.42K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$26.91K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $173.63K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $86.98K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$4.23M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$4.09M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$3.89M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$3.69M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.95M
Current Liabilities Q1 2026 · Dec 31, 2025 $4.78M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.08M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.92M
Current Assets Q1 2026 · Mar 31, 2026 $651.05K
Current Assets Q1 2026 · Dec 31, 2025 $563.42K
Total Assets Q1 2026 · Mar 31, 2026 $854.07K
Total Assets Q1 2026 · Dec 31, 2025 $830.42K
Eps Diluted Q1 2026 · Mar 31, 2026 $0.00
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.01
Eps Basic Q1 2026 · Mar 31, 2026 $0.00
Eps Basic Q1 2026 · Mar 31, 2025 −$0.01
Sga Expense Q1 2026 · Mar 31, 2026 $315.37K
Sga Expense Q1 2026 · Mar 31, 2025 $350.7K
Net Income Q1 2026 · Mar 31, 2026 $20.11K
Net Income Q1 2026 · Mar 31, 2025 −$38.56K
Operating Income Q1 2026 · Mar 31, 2026 $45.81K
Operating Income Q1 2026 · Mar 31, 2025 −$12.81K
Gross Profit Q1 2026 · Mar 31, 2026 $375.15K
Gross Profit Q1 2026 · Mar 31, 2025 $358.53K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $83.39K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $77.84K
Revenue Q1 2026 · Mar 31, 2026 $458.54K
Revenue Q1 2026 · Mar 31, 2025 $436.38K
Rd Expense Q1 2026 · Mar 31, 2025 $5.76K